Loo CE - Search Results

1

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.

Nederlof I, Isaeva OI, de Graaf M, Gielen RCAM, Bakker NAM, Rolfes AL, Garner H, Boeckx B, Traets JJH, Mandjes IAM, de Maaker M, van Brussel T, Chelushkin M, Champanhet E, Lopez-Yurda M, van de Vijver K, van den Berg JG, Hofland I, Klioueva N, Mann RM, Loo CE, van Duijnhoven FH, Skinner V, Luykx S, Kerver E, Kalashnikova E, van Dongen MGJ, Sonke GS, Linn SC, Blank CU, de Visser KE, Salgado R, Wessels LFA, Drukker CA, Schumacher TN, Horlings HM, Lambrechts D, Kok M. Nederlof I, et al. Among authors: loo ce. Nat Med. 2024 Nov;30(11):3223-3235. doi: 10.1038/s41591-024-03249-3. Epub 2024 Sep 16. Nat Med. 2024. PMID: 39284953 Free PMC article. Clinical Trial.

2

Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer.

Hannemann J, Oosterkamp HM, Bosch CA, Velds A, Wessels LF, Loo C, Rutgers EJ, Rodenhuis S, van de Vijver MJ. Hannemann J, et al. J Clin Oncol. 2005 May 20;23(15):3331-42. doi: 10.1200/JCO.2005.09.077. J Clin Oncol. 2005. PMID: 15908647 Clinical Trial.

3

Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.

Lips EH, Mukhtar RA, Yau C, de Ronde JJ, Livasy C, Carey LA, Loo CE, Vrancken-Peeters MJ, Sonke GS, Berry DA, Van't Veer LJ, Esserman LJ, Wesseling J, Rodenhuis S, Shelley Hwang E; I-SPY TRIAL Investigators. Lips EH, et al. Among authors: loo ce. Breast Cancer Res Treat. 2012 Nov;136(1):35-43. doi: 10.1007/s10549-012-2233-z. Epub 2012 Sep 8. Breast Cancer Res Treat. 2012. PMID: 22961065 Free PMC article.

4

Guiding breast-conserving surgery in patients after neoadjuvant systemic therapy for breast cancer: a comparison of radioactive seed localization with the ROLL technique.

Donker M, Drukker CA, Valdés Olmos RA, Rutgers EJ, Loo CE, Sonke GS, Wesseling J, Alderliesten T, Vrancken Peeters MJ. Donker M, et al. Among authors: loo ce. Ann Surg Oncol. 2013 Aug;20(8):2569-75. doi: 10.1245/s10434-013-2921-x. Epub 2013 Mar 6. Ann Surg Oncol. 2013. PMID: 23463088

5

Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.

Donker M, Straver ME, Wesseling J, Loo CE, Schot M, Drukker CA, van Tinteren H, Sonke GS, Rutgers EJ, Vrancken Peeters MJ. Donker M, et al. Among authors: loo ce. Ann Surg. 2015 Feb;261(2):378-82. doi: 10.1097/SLA.0000000000000558. Ann Surg. 2015. PMID: 24743607 Clinical Trial.

6

Using DRS during breast conserving surgery: identifying robust optical parameters and influence of inter-patient variation.

de Boer LL, Hendriks BH, van Duijnhoven F, Peeters-Baas MT, Van de Vijver K, Loo CE, Jóźwiak K, Sterenborg HJ, Ruers TJ. de Boer LL, et al. Among authors: loo ce. Biomed Opt Express. 2016 Nov 17;7(12):5188-5200. doi: 10.1364/BOE.7.005188. eCollection 2016 Dec 1. Biomed Opt Express. 2016. PMID: 28018735 Free PMC article.

7

MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy.

van Ramshorst MS, Loo CE, Groen EJ, Winter-Warnars GH, Wesseling J, van Duijnhoven F, Peeters MTV, Sonke GS. van Ramshorst MS, et al. Among authors: loo ce. Breast Cancer Res Treat. 2017 Jul;164(1):99-106. doi: 10.1007/s10549-017-4254-0. Epub 2017 Apr 21. Breast Cancer Res Treat. 2017. PMID: 28432515

8

Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.

Schmitz AMT, Teixeira SC, Pengel KE, Loo CE, Vogel WV, Wesseling J, Rutgers EJT, Valdés Olmos RA, Sonke GS, Rodenhuis S, Vrancken Peeters MJTFD, Gilhuijs KGA. Schmitz AMT, et al. Among authors: loo ce. PLoS One. 2017 May 22;12(5):e0176782. doi: 10.1371/journal.pone.0176782. eCollection 2017. PLoS One. 2017. PMID: 28531188 Free PMC article.

9

Surveillance of Dutch Patients With Li-Fraumeni Syndrome: The LiFe-Guard Study.

Ruijs MWG, Loo CE, van Buchem CAJM, Bleiker EMA, Sonke GS. Ruijs MWG, et al. Among authors: loo ce. JAMA Oncol. 2017 Dec 1;3(12):1733-1734. doi: 10.1001/jamaoncol.2017.1346. JAMA Oncol. 2017. PMID: 28772294 Free PMC article.

10

Complementary Value of Contralateral Parenchymal Enhancement on DCE-MRI to Prognostic Models and Molecular Assays in High-risk ER⁺/HER2^- Breast Cancer.

van der Velden BHM, Elias SG, Bismeijer T, Loo CE, Viergever MA, Wessels LFA, Gilhuijs KGA. van der Velden BHM, et al. Among authors: loo ce. Clin Cancer Res. 2017 Nov 1;23(21):6505-6515. doi: 10.1158/1078-0432.CCR-17-0176. Epub 2017 Aug 8. Clin Cancer Res. 2017. PMID: 28790119

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters